Islet cell carcinoma
Encyclopedia
Islet cell carcinoma or nesidioblastoma is an uncommon cancer
of the endocrine pancreas
.
It accounts for approximately 1.3% of pancreatic cancer
.
The term "nesidioblastoma" dates to at least 1938.
(SEER) national database have shown a median survival of about a decade for localized disease, six years for regional (confined to the region of the pancreas) and two years for those with distant disease.
Cancer
Cancer , known medically as a malignant neoplasm, is a large group of different diseases, all involving unregulated cell growth. In cancer, cells divide and grow uncontrollably, forming malignant tumors, and invade nearby parts of the body. The cancer may also spread to more distant parts of the...
of the endocrine pancreas
Pancreas
The pancreas is a gland organ in the digestive and endocrine system of vertebrates. It is both an endocrine gland producing several important hormones, including insulin, glucagon, and somatostatin, as well as a digestive organ, secreting pancreatic juice containing digestive enzymes that assist...
.
It accounts for approximately 1.3% of pancreatic cancer
Pancreatic cancer
Pancreatic cancer refers to a malignant neoplasm of the pancreas. The most common type of pancreatic cancer, accounting for 95% of these tumors is adenocarcinoma, which arises within the exocrine component of the pancreas. A minority arises from the islet cells and is classified as a...
.
The term "nesidioblastoma" dates to at least 1938.
Survival
Survival in islet cell carcinoma is highly dependent upon the degree of disease involvement; surgical cure is possible if the tumor is resected completely. Review articles using the Surveillance Epidemiology and End ResultsSurveillance Epidemiology and End Results
The Surveillance Epidemiology and End Results Program of the National Cancer Institute is a source of information on cancer incidence and survival in the United States.-The Program:...
(SEER) national database have shown a median survival of about a decade for localized disease, six years for regional (confined to the region of the pancreas) and two years for those with distant disease.